Dr Said Ismail, director of Qatar Genome Programme discusses the key ethical questions of precision medicine and what the industry needs to do to overcome them
Ray Chohan co-founder and vice president of new ventures at innovation intelligence expert Patsnap looks at technology’s ability to expedite the analysis of data in pharma and how it can help bring about new therapies for patients.
Advanced Workplace Associates founder Andrew Mawson and Chris Hood, director of Consulting, EMEA examine how pharmaceutical leaders can maximise the performance of any virtual or hybrid teams.
EPM speaks to Nigel Skinner, Marketing Director at Andrew Alliance about how automation is being used throughout the pharma industry and how it is helping bring new drugs to market faster.
Damiano Rossi, head of Applications – Particle Engineering and Microfluidics, Dolomite Microfluidics looks at how computational fluid dynamics modelling and AI are helping scientists predict the outcomes of microfluidic experiments.
European Pharmaceutical Manufacturer editor Reece Armstrong looks at the antibiotics landscape and why we need to speak up about antimicrobial resistance (AMR).
Marc Brown, Jon Lenn and Charles Evans, from MedPharm, discuss the latest industry innovations, the benefits of automation and mitigating the risk of product failure in the development of topical products.
Todd Sasser, head of Applications Americas & Senior NMI Applications Specialist at Bruker discusses how imaging techniques are helping drug developers better target tumours in cancer patients.
Danny Galbraith - head of New Services and Technology Management at Merck KGaA, Darmstadt, Germany, explores the innovation bringing RNA Therapeutics to the clinic.
